Concepedia

Kelly Chiang

KC

10

Publications

931

Citations

10

H-Index

2003

Active since

Affiliations

University of Birmingham(Current)

United States Food and Drug Administration

MRC Laboratory of Molecular Biology

Wellcome Sanger Institute

Center for Drug Evaluation and Research

Kelly Chiang is an author at University of Birmingham specializing in medicine, chromatin, and epigenomics.

Top concepts

Publications per year

2003–2024

10

Publications

10

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

Jaleh Fallah, Sundeep Agrawal, Haley Gittleman et al. · Clinical Cancer Research · 2022 · 200 citations · Full text

, , +14

PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression

Kelly Chiang, Agnieszka Zielińska, Abeer M. Shaaban et al. · Cell Reports · 2017 · 199 citations · Full text

, , +22

PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

Thomas L. Clarke, María Pilar Sánchez-Bailón, Kelly Chiang et al. · Molecular Cell · 2017 · 169 citations · Full text

Metabolic strategy of boar spermatozoa revealed by a metabolomic characterization

Silvia Marín, Kelly Chiang, Sara Bassilian et al. · FEBS Letters · 2003 · 164 citations · Full text

Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution

Pawandeep Dhami, Peter Saffrey, Alexander W. Bruce et al. · PLoS ONE · 2010 · 74 citations · Full text

, , +24

Rows per page

1–5 of 10